Tesamorelin 5mg: A Guide to Its Mechanism and Uses
Tesamorelin 5mg is a synthetic peptide analogue of human growth hormone-releasing factor primarily used to reduce abdominal fat in patients with HIV-associated lipodystrophy. It stimulates the pituitary gland, enhancing growth hormone secretion which aids in reducing visceral adipose tissue. Originally FDA-approved in 2010, tesamorelin addresses metabolic complications in HIV patients and improves abdominal composition and lipid profiles. Common side effects include joint pain and elevated blood sugar levels.

